Multispecific agents for treatment of cancer

The invention provides multispecific agents having one arm binding CD47, and a second arm binding to CD24. The invention also provides multispecific agents having one arm binding to SIRPa and a second arm binding to siglec-10.

Saved in:
Bibliographic Details
Main Author McCamish, Mark
Format Patent
LanguageEnglish
Published 18.01.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides multispecific agents having one arm binding CD47, and a second arm binding to CD24. The invention also provides multispecific agents having one arm binding to SIRPa and a second arm binding to siglec-10.
Bibliography:Application Number: AU20200245486